enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pharmacovigilance - Wikipedia

    en.wikipedia.org/wiki/Pharmacovigilance

    Worldwide, the most important aggregate report is the Periodic Safety Update Report (PSUR) and Development Safety Update Report (DSUR). This is a document that is submitted to drug regulatory agencies in Europe, the US and Japan (ICH countries), as well as other countries around the world.

  3. US obesity rates drop for 1st time in a decade, with possible ...

    www.aol.com/us-obesity-rates-drop-1st-160026522.html

    For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...

  4. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.

  5. Research on Adverse Drug Events and Reports - Wikipedia

    en.wikipedia.org/wiki/Research_on_Adverse_Drug...

    RADAR is led by Dennis West. Though it was without funding for its first four years, RADAR has raised about $12 million through grants from the National Institutes of Health, the American Cancer Society and other such institutions. Its work has identified safety problems with 33 drugs. Adverse drug events are a serious health problem.

  6. Obesity Rates in the U.S. Drop for the First Time in a Decade ...

    www.aol.com/obesity-rates-u-drop-first-204508332...

    The study followed nearly 17 million people, the majority of whom were in the 26-75 age range, and found that after climbing steadily since 2013, rates of obesity in the U.S. fell 0.15% in 2023 ...

  7. Weight-loss drugs could boost US GDP by 1% in coming years ...

    www.aol.com/news/weight-loss-drugs-could-boost...

    (Reuters) - The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely ...

  8. VigiBase - Wikipedia

    en.wikipedia.org/wiki/VigiBase

    VigiBase is a World Health Organization's (WHO) global Individual Case Safety Report (ICSR) database that contains ICSRs submitted by the participating member states enrolled under WHO's international drug monitoring programme. It is the single largest drug safety data repository in the world.

  9. Shortage of blockbuster anti-obesity drug ends: What to know ...

    www.aol.com/news/shortage-blockbuster-anti...

    What to know about who is eligible, how it works, cost, side effects and insurance coverage as drug shortage ends. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...